Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
The deal will open up more opportunities to study OmniSeq's 144-gene NGS test and Immune Report Card in real-world settings and as part of drug development trials.
Investigators studied 442 patients with CUP and found mutations that could inform a specific treatment decision in more than half of them.
Using blood samples from 200 cancer patients, researchers showed that it is possible to find most early cancer cases with targeted error correction sequencing.
Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark.
Caprion will use its mass spec platform to measure Alzheimer's-linked proteins in the CSF of more than 200 patients and controls over three or more years.
The agricultural company said it will use the licensed technology to develop improved and sustainable crops.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.